Joseph Payne
Founder, President, CEO & Director
Good morning, and welcome to the 2026 Annual Meeting of Stockholders of Arcturus Therapeutics Holdings, Inc. We are holding this year’s annual meeting as an entirely virtual meeting. Stockholders who require technical assistance during the meeting can call Continental’s technical support line at the phone number posted on the meeting log-in page. I’m Joe Payne, President and CEO as well as member of the Board of Directors. It is now 9:00 a.m. on June 5, 2026, and this meeting will please come to order. Also participating in this meeting are Dr. Pad Chivukula, Chief Scientific Officer and Chief Operating Officer of the company, Lance Kurata, the company’s Chief Legal Officer and Secretary of the meeting, Alwyn Burton of Continental Stock Transfer & Trust Company, who has been appointed as Inspector of Election and Stockholders votes of the meeting, and KC Freer and [ Devin ] Gibson of Deloitte & Touche, LLP, independent registered accountants of the company. Members of our Board of Directors are also participating in this meeting.
I would now like to proceed with the formal business of the meeting. As a preliminary matter, we note that stockholders may submit questions through the virtual meeting website at any time during the meeting. The company will, at its discretion, provide answers to properly raised and appropriate questions on the Investor Relations section of its website after the meeting. And KC Freer and [ Devin ] Gibson may also respond to properly raised and appropriate questions directed to Deloitte.
I will act as Chairperson of the meeting, and Mr. Kurata
